TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA
This study is currently recruiting participants.
Verified November 2012 by Keimyung University Dongsan Medical Center
Sponsor:
Keimyung University Dongsan Medical Center
Collaborators:
Kyungpook National University
Daegu Catholic University Medical Center
DongGuk University
Pusan National University Hospital
Yeungnam University
Information provided by (Responsible Party):
Jang Byoung Kuk, Keimyung University Dongsan Medical Center
ClinicalTrials.gov Identifier:
NCT01732367
First received: November 19, 2012
Last updated: November 25, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | May 2015 |
| Estimated Primary Completion Date: | May 2015 (Final data collection date for primary outcome measure) |